Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 121 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT05951816
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
- Locations
-
- University of Tennessee Graduate School of Medicine Knoxville, Tennessee, United States
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +9 more
- Locations
-
- GSK Investigational Site Rochester, Minnesota, United States
- GSK Investigational Site Westmead, New South Wales, Australia
- GSK Investigational Site Woolloongabba, Queensland, Australia
- GSK Investigational Site Box Hill, Victoria, Australia
Teclistamab-Daratumumab in AL Amyloidosis
NCT07110844
- Conditions
- Amyloid Light-chain Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Boston Medical Center Boston, Massachusetts, United States
- Columbia University Irving Medical Center New York, United States
- Medical College of Wisconsin Milwaukee, Wisconsin, United States
Registry of Older Patients With Cancer
NCT01137825
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
- Locations
-
- Seby B. Jones Cancer Center Boone, North Carolina, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
- East Carolina University Greenville, North Carolina, United States
- Pardee Cancer Center Hendersonville, North Carolina, United States
NCT05145816
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States
- UT Southwestern Medical Center Dallas, Texas, United States
- Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States
NCT06022939
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
NCT05898646
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT01408225
- Conditions
- AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +21 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT06569147
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00898235
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
- Locations
-
- Boston University Cancer Research Center Boston, Massachusetts, United States
NCT02641145
- Conditions
- Amyloidosis, Amyloidosis, Primary, Cardiomyopathies, +14 more
- Locations
-
- Brigham and Womens' Hospital Boston, Massachusetts, United States
NCT01137643
- Conditions
- Amyloidosis, Anemia, Anemia, Aplastic, +98 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
NCT06365060
- Conditions
- Amyloidosis, Blood Protein Disorders, Hematologic Diseases, +15 more
- Locations
-
- University of Alabama Hospital Birmingham, Alabama, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States
- Cleveland Clinic Florida, Weston Hospital Weston, Florida, United States
NCT00935090
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement
NCT07615270
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Stanford University Palo Alto, California, United States
Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis
NCT07524634
- Conditions
- Amyloid Light-chain Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
NCT03283917
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT05184088
- Conditions
- AL Amyloidosis, ATTR Amyloidosis, Amyloid Neuropathies, +23 more
- Locations
-
- St Luke's Hospital Kansas City, Kansas, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
- University of Augsburg Augsburg, Germany
NCT03431896
- Conditions
- AL Amyloidosis, Alzheimer Disease, Amyloid, +33 more
- Locations
-
- Cleveland Clinic Cleveland, Ohio, United States
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
NCT01758042
- Conditions
- AL Amyloidosis, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), +73 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States